James Linnick
Family Medicine · Independence, MONPI 1417961988
Payments from drug & device makers
Across 407 payments — averaging $14.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$876
- Lilly USA, LLC$646
- AbbVie$604
- Pfizer$509
- Boehringer Ingelheim$500
- Novo Nordisk$423
- plus $2K from 23 others
What the payments were for
- Food & beverage$5,865100%
- Education$80%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 47 | $876 |
| Lilly USA, LLC | 43 | $646 |
| AbbVie | 51 | $604 |
| Pfizer | 41 | $509 |
| Boehringer Ingelheim | 33 | $500 |
| Novo Nordisk | 39 | $423 |
| GSK | 23 | $374 |
| Vanda Pharmaceuticals Inc. | 15 | $296 |
| Abbott | 22 | $243 |
| Astellas Pharma US Inc | 10 | $185 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 12 | $174 |
| Merck | 10 | $134 |
| Biohaven Pharmaceutical Holding Company Ltd. | 8 | $120 |
| Eisai Inc. | 7 | $112 |
| Novartis | 7 | $108 |
| Amgen | 7 | $101 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $77 |
| Bayer | 4 | $69 |
| Philips North America LLC | 2 | $50 |
| Mylan Specialty L.p. | 4 | $48 |
| Sanofi-aventis U.S. LLC | 3 | $38 |
| Esperion Therapeutics, Inc. | 2 | $34 |
| Idorsia Pharmaceuticals US Inc | 2 | $33 |
| Johnson & Johnson | 2 | $27 |
| Biohaven Pharmaceuticals, Inc. | 2 | $25 |
| Kowa Pharmaceuticals America, Inc. | 2 | $23 |
| Sunovion Pharmaceuticals Inc. | 2 | $22 |
| Exact Sciences | 1 | $13 |
| Genentech USA, Inc. | 1 | $12 |
How this compares
$5,874 in reported general payments places this provider in the 90th percentile of 2,203 family medicine providers in Missouri.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 119 | $145,479 |
| MounjaroTirzepatide | 36 | $51,881 |
| JardianceEmpagliflozin | 45 | $45,193 |
| XareltoRivaroxaban | 22 | $33,941 |
| Spiriva RespimatTiotropium Bromide | 37 | $29,786 |
| EliquisApixaban | 29 | $23,684 |
| FarxigaDapagliflozin Propanediol | 11 | $19,642 |
| VraylarCariprazine Hcl | 12 | $17,453 |
| Tresiba Flextouch U-200Insulin Degludec | 13 | $12,648 |
| SymbicortBudesonide/Formoterol Fumarate | 33 | $12,354 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 71 | $9,248 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 244 | $7,564 |
| Repatha SyringeEvolocumab | 13 | $7,334 |
| ShingrixVaricella-Zoster Ge/As01b/Pf | 32 | $7,085 |
| Insulin Lispro Kwikpen U-100Insulin Lispro | 13 | $6,565 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $423 | $145,479119 claims |
| Boehringer IngelheimJardiance, Spiriva Respimat | $500 | $74,97982 claims |
| Lilly USA, LLCMounjaro | $646 | $51,88136 claims |
| Johnson & JohnsonXarelto | $27 | $33,94122 claims |
| AstraZenecaFarxiga, Symbicort | $876 | $31,99644 claims |
| PfizerEliquis | $509 | $23,68429 claims |
| AbbVieVraylar, Synthroid | $604 | $20,32933 claims |
| GSKShingrix | $374 | $7,08532 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 2,203 family medicine providers in Missouri.
Other family medicine in Independence
- Timothy JenningsMaryland Heights$30.2M
- William HowittSpringfield$19.9M
- Rupal TrivediSaint Louis$10.6M
- Frederic PraterMaryland Heights$9.1M
- Leea ReedRogersville$7.9M
- Dennis MorrisonSpringfield$5.7M
- Luke van KirkSpringfield$5.6M
- Amy RobertsTown And Country$4M
- Scott KuennenKansas City$2.2M
- George CarrJefferson City$2.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.